WO2011069474A2 - Dérivé oxydé d'acide hyaluronique, procédé d'élaboration et procédé de modification - Google Patents

Dérivé oxydé d'acide hyaluronique, procédé d'élaboration et procédé de modification Download PDF

Info

Publication number
WO2011069474A2
WO2011069474A2 PCT/CZ2010/000128 CZ2010000128W WO2011069474A2 WO 2011069474 A2 WO2011069474 A2 WO 2011069474A2 CZ 2010000128 W CZ2010000128 W CZ 2010000128W WO 2011069474 A2 WO2011069474 A2 WO 2011069474A2
Authority
WO
WIPO (PCT)
Prior art keywords
hyaluronic acid
oxidized
hyaluronan
acid derivative
water
Prior art date
Application number
PCT/CZ2010/000128
Other languages
English (en)
Other versions
WO2011069474A3 (fr
Inventor
Radovan Buffa
Sofiane Kettou
Lucie POSPIŠILOVÁ
Miroslava BERKOVÁ
Vladimir VELEBNÝ
Original Assignee
Contipro C A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contipro C A.S. filed Critical Contipro C A.S.
Priority to BR112012013954A priority Critical patent/BR112012013954B8/pt
Priority to RU2012122313/13A priority patent/RU2550602C2/ru
Priority to KR1020127017920A priority patent/KR101710432B1/ko
Priority to JP2012542355A priority patent/JP5945504B2/ja
Priority to EP10812976.8A priority patent/EP2510017B1/fr
Priority to ES10812976T priority patent/ES2531292T3/es
Priority to PL10812976T priority patent/PL2510017T3/pl
Priority to US13/514,759 priority patent/US9403918B2/en
Priority to DK10812976.8T priority patent/DK2510017T3/en
Publication of WO2011069474A2 publication Critical patent/WO2011069474A2/fr
Publication of WO2011069474A3 publication Critical patent/WO2011069474A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Definitions

  • the oxidation can be performed by use of DMP (Dess-Martin Periodinane) agent in polar aprotic solvents,
  • solvent includes for example dimethylsulfoxide.
  • Hyaluronic acid is an important polysaccharide, composed of two repeating units of ⁇ - -(l,3)-D-glucuronic acid and P-(l,4)-N-acetyl-D-glucosamine.
  • the molecular weight depending on the method its isolation and on the source material, is within the range from 5.10 4 to 5.10 6 g-mol "1 .
  • Hyaluronic acid or its sodium salt hyaluronan is an essential component of connective tissues, synovial fluid of joints, and plays an important role in biological processes such as hydratation, organization of proteoglycans, cells differentiation, proliferation and angiogenesis.
  • Hyaluronic acid is a considerably hydrophilic polysaccharide that is water-soluble in the form of its salt within the whole range of pH.
  • Oxidation of polysaccharides is a process in which the oxidation degree of the polysaccharide functional groups is changing. Most frequently, the carboxylic acids or aldehydes are formed, which can dramatically change the properties of the polysaccharide. In most cases, the reaction is performed by use of agents containing atoms in higher oxidation degrees.
  • the oxidation of cyclodextrin to monoaldehyde was described by Cornwell, Tetrahedron Letters 1995, 36 (46), 8371 - 8374.
  • the oxidation was performed by adding Dess-Martin periodinane (DMP) in DMSO or in DMF at the temperature of 20°C as an oxidizing agent.
  • DMP Dess-Martin periodinane
  • Oxidation of hyaluronan by use of TEMPO/NaCIO system was described in the patent application WO 02/18448 A2. The authors also dealt with interactions of percarboxylated polysaccharides, while forming biological complexes.
  • the physico-chemical properties of the resulting hydrogels have been elucidated by instrumental analyses FT-IR, SEM (scanning electron microscopy) and rheometry. Increasing the oxidation degree of the hyaluronan lead to a corresponding increase of hydrogels compatibility and decrease of water absorption capacity. Dermal fibroblasts were used to study the cell-hydrogel interactions. Both the hydrogels and their degradation products are biocompatible, as proved by the long-term cell viability assay. When cultured with cells, the hydrogel underwent a degradation within 4 weeks, with an obvious loss of cohesiveness. The good biocompatibility and biodegradability was further demonstrated in mice subdermal implantations. Lastly, in vitro and in vivo depositions of extracellular matrix in hydrogels were demonstrated by SEM analysis.
  • the present invention relates to a method of selective oxidation of the primary hydroxyl group of hyaluronic acid in position 6 of the glucosamine part of the polysaccharide to aldehyde.
  • the reaction is performed in an aprotic environment by use of Dess-Martin periodinane DMP as an oxidizing agent.
  • the presented procedure is original in that it introduces an aldehydic group to the position 6 of the hyaluronan glucosamine part (scheme 6, structure 3).
  • the method according to the invention is more advantageous in that the respective oxidation product (structure 3, scheme 6) maintains the structure of conjugated saccharide rings. Ring opening in the product oxidized to dialdehyde (structure 2, scheme 6) gives rise to the chain linearity subreakage" and, therefore, a significant change of the polysaccharide 3- dimensional structure compared to the non-modified hyaluronan. Although in the product oxidized to a carboxylic acid (structure 1, scheme 6) the chain linearity impartbreakage" does not occur, the carboxyl group does not enable such various modification (binding) possibilities like the aldehydic group.
  • the oxidation to the structure 1 brings only an increase of the polysaccharide polarity, not a development of new quality utilizable for binding new substitutes.
  • the prepared oxidized hyaluronan can be used for binding of compounds containing for example amino group.
  • the binding can be realized either in an imine form or after the
  • the modification of the hyaluronic acid derivative can be performed by a reaction of the oxidized derivative with an amine of the general formula H 2 N-R or with a hyaluronan substituted by an -R-N3 ⁇ 4 group, wherein R is an alkyl, linear or branched chain CI- C30, optionally containing aromatic or heteroaromatic groups.
  • This amine can be an alkylamine, e.g. butylamine or hexanediamine, amino acid, peptide or polysaccharide containing a free amino group.
  • cross-linked hyaluronan derivatives can be prepared.
  • the cross-linked derivatives can be prepared also by the reaction of an aldehyde with a hyaluronan substituted by an aminoalkyl group HA-alkyl-NH 2 .
  • equivalent (eq) refers to a hyaluronic acid dimer, unless otherwise indicated.
  • the percentages as used herein mean a percentage by weight, unless otherwise indicated..
  • the molecular weight of the starting hyaluronan was determined by the SEC-MALLS assay.
  • logD (3.05 ppm, polymer-CH 2 -NH-CH2-) ⁇ -10.3 m 2 /s logD (2.03 ppm, CH 3 -CO-NH-polymer) ⁇ -10.3 m 2 /s
  • Example 3 was mixed with hexanediamine (0.4 eq). The mixture was stirred for 24 hours at the temperature of 20°C. The solution was then mixed with NaBH 3 CN (3 eq) in 0.5 ml of water. The mixture was stirred for 24 hours at the temperature of 20°C. The solution was then diluted to 0.1% and dialyzed against the mixture (0.1% NaCl, 0.1% NaHC0 3 ) 3 x 5 liters (once per day) and against distilled water 7 x 5 liters (twice per day). The resulting solution was evaporated and analyzed.
  • logD (1.7 ppm, -NH-CH 2 -CH 2 -CH 2 -CH 2 -CH 2 -) ⁇ -10.5 m 2 /s logD (3.02 ppm, -CH 2 -NH 2 ) ⁇ -10.5 m 2 /s
  • Example 4 was mixed with lysine (20 eq). The mixture was stirred for 24 hours at the temperature of 20°C. The solution was then mixed with NaBH 3 CN (10 eq) in 0.5 ml of water. The mixture was stirred for 24 hours at the temperature of 20°C. The solution was diluted to 0.1% and dialyzed against the mixture (0.1% NaCl, 0.1% NaHC0 3 ) 3 x 5 liters (once per day) and against distilled water 7 x 5 liters (twice per day). The resulting solution was then evaporated and analyzed.
  • a solution of the oxidized hyaluronic acid (1%) (0.1 g, oxidation degree DS 10 %, Example 1) in a water/isopropanol system 2/1 was mixed with a 1% solution of substituted pentapeptide PAL-KTTKS (0.05 eq) in isopropyl alcohol. The mixture was stirred for 24 hours at the temperature of 20°C. The solution was then mixed with NaBH 3 CN (3 eq) in 0.5 ml of water. The mixture was stirred for 24 hours at the temperature of 20°C.
  • the solution was diluted to 0.1% and dialyzed against the mixture (0.1% NaCl, 0.1% NaHC0 3 ) 3 x 5 liters (once per day) and against distilled water 7 x 5 liters (twice per day). The resulting solution was evaporated and analyzed.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne le procédé d'élaboration et de modification d'un dérivé hyaluronane à groupe adhéhydique en position (6) de la partie glucosamine de polysaccharide. L'oxydation de l'acide hyaluronique peut s'effectuer au moyen d'un agent periodinane de Dess-martin (DMP). L'aldhéhyde élaboré peut être utilisé pour la liaison d'amine, de diamine, d'acide aminé, de peptide et d'autres composés contenant un groupe amino, par exemple au moyen de l'amination réductive avec NaBH3CN dans l'eau ou dans un système eau-solvant organique. Lorsque diamine ou des composés contenant trois ou plus de trois groupes aminés sont utilisés, il est possible d'élaborer des dérivés hyaluronane réticulés. Des dérivés réticulés peuvent aussi être élaborés par la réaction de l'aldéhyde avec un hyaluronane substitué par un groupe amino-alkyle HA-alkyl-NH2.
PCT/CZ2010/000128 2009-12-11 2010-12-10 Dérivé oxydé d'acide hyaluronique, procédé d'élaboration et procédé de modification WO2011069474A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BR112012013954A BR112012013954B8 (pt) 2009-12-11 2010-12-10 derivado de ácido hialurônico, método de preparação do derivado de ácido hialurônico
RU2012122313/13A RU2550602C2 (ru) 2009-12-11 2010-12-10 Производное гиалуроновой кислоты, способ его получения и способ его модификации
KR1020127017920A KR101710432B1 (ko) 2009-12-11 2010-12-10 히알루론산의 산화된 유도체, 이의 제조 방법 및 이의 변형 방법
JP2012542355A JP5945504B2 (ja) 2009-12-11 2010-12-10 ヒアルロン酸の酸化誘導体，その調製方法及びその修飾方法
EP10812976.8A EP2510017B1 (fr) 2009-12-11 2010-12-10 Dérivé oxydé d'acide hyaluronique, procédé d'élaboration et procédé de modification
ES10812976T ES2531292T3 (es) 2009-12-11 2010-12-10 Derivado oxidado del ácido hialurónico, un método para su preparación y un método para su modificación
PL10812976T PL2510017T3 (pl) 2009-12-11 2010-12-10 Utleniona pochodna kwasu hialuronowego, sposób jej wytwarzania i sposób jej modyfikacji
US13/514,759 US9403918B2 (en) 2009-12-11 2010-12-10 Oxidized derivative of hyaluronic acid, a method of preparation thereof and a method of modification thereof
DK10812976.8T DK2510017T3 (en) 2009-12-11 2010-12-10 Oxidized derivative of hyaluronic acid, a process for its preparation and a process for its modification

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZPV2009-836 2009-12-11
CZ20090836A CZ302504B6 (cs) 2009-12-11 2009-12-11 Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace

Publications (2)

Publication Number Publication Date
WO2011069474A2 true WO2011069474A2 (fr) 2011-06-16
WO2011069474A3 WO2011069474A3 (fr) 2013-03-14

Family

ID=43971822

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CZ2010/000128 WO2011069474A2 (fr) 2009-12-11 2010-12-10 Dérivé oxydé d'acide hyaluronique, procédé d'élaboration et procédé de modification

Country Status (11)

Country Link
US (1) US9403918B2 (fr)
EP (1) EP2510017B1 (fr)
JP (1) JP5945504B2 (fr)
KR (1) KR101710432B1 (fr)
BR (1) BR112012013954B8 (fr)
CZ (1) CZ302504B6 (fr)
DK (1) DK2510017T3 (fr)
ES (1) ES2531292T3 (fr)
PL (1) PL2510017T3 (fr)
RU (1) RU2550602C2 (fr)
WO (1) WO2011069474A2 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013159757A1 (fr) * 2012-04-25 2013-10-31 Contipro Biotech S.R.O. Dérivé d'hyaluronane réticulé, son procédé de préparation, hydrogel et microfibres à base du dérivé
WO2014023272A1 (fr) 2012-08-08 2014-02-13 Contipro Biotech S.R.O. Dérivé d'acide hyaluronique, procédé de préparation de celui-ci, procédé de modification de celui-ci et d'utilisation de celui-ci
WO2014082610A1 (fr) 2012-11-27 2014-06-05 Contipro Biotech S.R.O. Fibres sans fin à base d'hyaluronane sélectivement oxydé en position 6 du groupe n-acétyl-d-glucosamine, leur préparation et utilisation, filés, fibres courtes, fils et tissus constitués de celles-ci et procédé pour la modification de celles-ci
KR20140136922A (ko) * 2012-02-07 2014-12-01 (주)화이바이오메드 경피 전달용 히알루론산-단백질 컨쥬게이트의 제조 방법 및 이에 따라 제조된 경피 전달용 히알루론산-단백질 컨쥬게이트
US9403918B2 (en) 2009-12-11 2016-08-02 Contipro Pharma A.S. Oxidized derivative of hyaluronic acid, a method of preparation thereof and a method of modification thereof
US9434791B2 (en) 2009-12-11 2016-09-06 Contipro Pharma A.S. Method of preparation of an oxidized derivative of hyaluronic acid and a method of modification thereof
US9492586B2 (en) 2012-02-28 2016-11-15 Contipro Biotech S.R.O. Derivatives of hyaluronic acid capable of forming hydrogels
WO2016202314A1 (fr) 2015-06-15 2016-12-22 Contipro A.S. Procédé de réticulation de polysaccharides à l'aide de groupes protecteurs photoamovibles
WO2016206661A1 (fr) 2015-06-26 2016-12-29 Contipro A.S. Dérivés de polysaccharides sulfatés, procédé de préparation, modification et utilisation correspondants
US9999678B2 (en) 2012-11-27 2018-06-19 Contipro A.S. C6-C18-acylated derivative of hyaluronic acid and method of preparation thereof
US10023658B2 (en) 2014-03-11 2018-07-17 Contipro A.S. Conjugates of oligomer of hyaluronic acid or of a salt thereof, method of preparation thereof and use thereof
CZ308106B6 (cs) * 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
US10617711B2 (en) 2014-06-30 2020-04-14 Contipro A.S. Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof
US10689464B2 (en) 2015-03-09 2020-06-23 Contipro A.S. Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304072B6 (cs) * 2011-04-26 2013-09-25 Contipro Biotech S.R.O. Amfoterní materiál na bázi sítované kyseliny hyaluronové, zpusob jeho prípravy, materiály obsahující aktivní cinidla uzavrené v síti hyaluronanu, zpusob jejich prípravy a jejich pouzití
CZ303722B6 (cs) * 2012-01-16 2013-04-03 Contipro Biotech S.R.O. Kyselina hyaluronová znacená tritiem, zpusob znacení kyseliny hyaluronové tritiem a její pouzití
KR101664444B1 (ko) * 2013-12-13 2016-10-12 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 생분해성 의료용 접착제 또는 실란트 조성물
US20210008249A1 (en) 2018-03-12 2021-01-14 Merz Pharma Gmbh & Co. Kgaa Porous biomaterials for tissue regeneration
WO2023056433A1 (fr) * 2021-10-01 2023-04-06 Northwestern University Suspension épaisse composite supramoléculaire-covalente pour la réparation de cartilage
CN116789869A (zh) * 2023-06-25 2023-09-22 吉林省奇健生物技术有限公司 一种透明质酸-蛋白偶联体的制备方法及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018448A2 (fr) 2000-08-31 2002-03-07 Fidia Farmaceutici S.P.A. Polysaccharides percaboxyles, et procede d'elaboration
US6683064B2 (en) 1997-07-03 2004-01-27 Depuy Acromed, Inc. Cross-linked polysaccharide drug carrier

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3720662A (en) 1971-09-13 1973-03-13 Nat Starch Chem Corp Preparation of starch esters
US3728223A (en) 1971-10-08 1973-04-17 Amano Pharma Co Ltd Production of hyaluronidase from a strain of streptomyces
CH628088A5 (en) 1975-09-17 1982-02-15 Dresden Arzneimittel Process for obtaining streptococcal metabolic products
US4205025A (en) 1975-12-22 1980-05-27 Champion International Corporation Synthetic polymeric fibrids, fibrid products and process for their production
JPS6033474B2 (ja) 1978-05-11 1985-08-02 藤沢薬品工業株式会社 新規なヒアルロニダ−ゼｂｍｐ−８２３１およびその製造法
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
GB8519416D0 (en) 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
JPS62104579A (ja) 1985-10-30 1987-05-15 Kyowa Hakko Kogyo Co Ltd ヒアルロニダ−ゼの製造法
JPH0751064B2 (ja) 1986-08-13 1995-06-05 生化学工業株式会社 新規なヒアルロニダ−ゼｓｄ−６７８およびその製造法
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
JPH0214019A (ja) 1988-06-30 1990-01-18 Tonen Corp 繊維状成形物及びその製造方法
US5824335A (en) 1991-12-18 1998-10-20 Dorigatti; Franco Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives
IT1254704B (it) 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
JP2855307B2 (ja) 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
FR2689131B1 (fr) 1992-03-30 1994-05-20 Oreal Procede de preparation de monoesters majoritairement en position 6' du d-maltose et leur utilisation dans les domaines cosmetique, bucco-dentaire, pharmaceutique et alimentaire.
JPH0625306A (ja) 1992-04-21 1994-02-01 Shiseido Co Ltd 溶媒不溶化ヒアルロン酸及びその製造方法
IT1263316B (it) 1993-02-12 1996-08-05 Fidia Advanced Biopolymers Srl Tessuto non tessuto multistrato in cui uno degli strati e' costituito essenzialmente da esteri dell'acido ialuronico
NL9700003A (nl) 1993-09-28 1997-07-01 House Foods Corp Werkwijze voor het inoculeren van Fistulina hepatica.
US5616568A (en) 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
CN1128065A (zh) 1994-03-14 1996-07-31 生化学工业株式会社 戴在眼球上的材料
US5455349A (en) 1994-05-13 1995-10-03 Polaroid Corporation Vinylbenzyl thymine monomers
US6025444A (en) 1994-11-17 2000-02-15 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Cinnamic acid derivative
US5690961A (en) 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US6011149A (en) 1995-03-07 2000-01-04 Novartis Ag Photochemically cross-linked polysaccharide derivatives as supports for the chromatographic separation of enantiomers
AU718484B2 (en) 1995-08-29 2000-04-13 Fidia Advanced Biopolymers S.R.L. Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives
EP0763754B1 (fr) 1995-09-13 2003-01-08 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Lentille de contact à base d'acide hyaluronique photoréticulé
DE19604706A1 (de) 1996-02-09 1997-08-14 Merck Patent Gmbh Vernetzungsprodukte von Aminogruppen-haltigen Biopolymeren
DE19616010C2 (de) 1996-04-23 1998-07-09 Seitz Filter Werke Verfahren und Vorrichtung zur Herstellung von Fibrets (Fibriden) aus Zellulosederivaten
US6632802B2 (en) 1996-08-29 2003-10-14 Fidia Advanced Biopolymers S.R.L. Hyaluronic acid esters, threads and biomaterials containing them, and their use in surgery
IT1287698B1 (it) 1996-08-29 1998-08-18 Fidia Advanced Biopolymers Srl Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico
ATE302785T1 (de) 1998-04-30 2005-09-15 Maruha Corp Verbindungen, deren struktur derivate von glukuronsäure und glukosamin enthält, verfahren zu deren herstellung und deren verwendung
ES2174605T3 (es) * 1998-05-07 2002-11-01 Tno Procedimiento para la oxidacion selectiva de alcoholes primarios.
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
IT1302534B1 (it) 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
EP1140199B1 (fr) 1998-12-23 2003-07-23 Esparma GmbH Hyaluronate lyase utilisee dans des medicaments topiques comme agent facilitant leur penetration
DE19917614C2 (de) 1999-04-19 2001-07-05 Thueringisches Inst Textil Verfahren zur Herstellung von cellulosischen Formkörpern mit hohem Adsorptionsvermögen
US6288043B1 (en) * 1999-06-18 2001-09-11 Orquest, Inc. Injectable hyaluronate-sulfated polysaccharide conjugates
US6592794B1 (en) 1999-09-28 2003-07-15 Organogenesis Inc. Process of making bioengineered collagen fibrils
WO2001034657A1 (fr) 1999-11-08 2001-05-17 Sca Hygiene Products Zeist B.V. Procede d'oxydation d'alcools primaires
DE10003397A1 (de) 2000-01-27 2001-08-09 Hartmann Paul Ag Polyelektrolyt-Feststoffsystem, Verfahren zur Herstellung desselben sowie Wundverband
IT1317358B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
US6498269B1 (en) * 2000-10-17 2002-12-24 The University Of Connecticut Method for the oxidation of aldehydes, hemiacetals and primary alcohols
WO2002048197A1 (fr) 2000-12-13 2002-06-20 Sca Hygiene Products Zeist B.V. Procede d'oxydation d'alcools primaires
DE60117502T2 (de) 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material
FR2819808B1 (fr) * 2001-01-19 2003-04-18 Simafex Compositions stabilisees d'acide o-iodoxybenzoique et leur procede de preparation
WO2002060971A1 (fr) 2001-01-31 2002-08-08 Seikagaku Corporation Eponge polysaccharidique reticulee
US6902548B1 (en) 2001-03-19 2005-06-07 Ed Schuler Use of Streptomyces hyalurolyticus enzyme in ophthalmic treatments
US6673919B2 (en) 2001-03-30 2004-01-06 Chisso Cororation Chemically modified hyaluronic acid or salts thereof, and a process for producing thereof
US6946284B2 (en) 2001-11-16 2005-09-20 University Of Massachusetts Solubilizing cross-linked polymers with photolyase
US20060189516A1 (en) 2002-02-19 2006-08-24 Industrial Technology Research Institute Method for producing cross-linked hyaluronic acid-protein bio-composites
US6762327B2 (en) * 2002-04-29 2004-07-13 Wyeth Selective oxidation process with enhanced safety
JP3975267B2 (ja) 2002-06-03 2007-09-12 独立行政法人産業技術総合研究所 多糖物質のアシル化方法
US20040101546A1 (en) 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US7550136B2 (en) 2002-12-20 2009-06-23 University Of Massachusetts Photo-reactive polymers and devices for use in hair treatments
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
FR2852012B1 (fr) 2003-03-04 2006-06-23 Oreal Procede de preparation de derives o-acyles du glucose
EP1607405B1 (fr) 2003-03-11 2011-05-04 Seikagaku Corporation Composition polysaccharide photoreticulee et procede de fabrication
DE10331342B4 (de) 2003-07-11 2009-03-12 Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. Thermostabile Form- oder Spinnmasse
WO2005028632A2 (fr) 2003-09-19 2005-03-31 Colorado State University Research Foundation (Csurf) Esterification du hyaluronan par acylation pour des dispositifs moulables
US8313765B2 (en) 2003-12-04 2012-11-20 Industrial Technology Research Institute Biodegradable hyaluronic acid derivative, biodegradable polymeric micelle composition and pharmaceutical or bioactive composition
GB2408741B (en) 2003-12-04 2008-06-18 Ind Tech Res Inst Hyaluronic acid derivative with urethane linkage
US20100330143A1 (en) 2003-12-04 2010-12-30 University Of Utah Research Foundation Modified macromolecules and methods of making and using thereof
WO2006010066A2 (fr) 2004-07-09 2006-01-26 The Cleveland Clinic Foundation Reseau macromoleculaire reticule de hydroxyphenyle et applications associees
US7323425B2 (en) 2004-08-27 2008-01-29 Stony Brook Technology And Applied Research Crosslinking of hyaluronan solutions and nanofiberous membranes made therefrom
US7214759B2 (en) * 2004-11-24 2007-05-08 Advanced Cardiovascular Systems, Inc. Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same
CN101107270B (zh) 2004-11-24 2011-11-23 诺维信生物制药丹麦公司 用二乙烯基砜交联透明质酸的方法
US7680038B1 (en) 2005-04-25 2010-03-16 Electronic Arts, Inc. Dynamic bandwidth detection and response for online games
GB0513552D0 (en) 2005-07-01 2005-08-10 Bristol Myers Squibb Co Bandage
JP5147396B2 (ja) 2005-07-06 2013-02-20 生化学工業株式会社 薬剤導入光架橋ヒアルロン酸誘導体ゲル
ITPD20050206A1 (it) 2005-07-07 2007-01-08 Fidia Advanced Biopolymers Srl Biomateriali in forma di fibra da impiegarsi come dispositivi medici nel trattamento delle ferite e loro processi di produzione
ITMI20051415A1 (it) 2005-07-22 2007-01-23 Fidia Advanced Biopolymers Srl Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione
US7993678B2 (en) 2005-09-26 2011-08-09 Novozymes Biopolymer A/S Hyaluronic acid derivatives
EP3028677A1 (fr) 2005-12-14 2016-06-08 Anika Therapeutics Inc. Traitement de l'arthrite et d'autres troubles musculosquelettiques avec de l'acide hyaluronique réticulé
US20070202570A1 (en) 2006-02-24 2007-08-30 Kikkoman Corporation Enzyme composition, low molecular weight hyaluronan and process for preparing the same
JP4892679B2 (ja) 2006-03-27 2012-03-07 国立大学法人弘前大学 ゲル紡糸によるヒアルロン酸繊維およびその製造方法
KR20070118730A (ko) 2006-06-13 2007-12-18 주식회사 코오롱 보습성이 우수한 창상피복재 및 그의 제조방법
US20080124395A1 (en) 2006-06-22 2008-05-29 Weiliam Chen Formulations and devices for treatment or prevention of neural ischemic damage
US20080063617A1 (en) 2006-09-07 2008-03-13 Abrahams John M Cosmetics formulations
ITMI20061726A1 (it) 2006-09-11 2008-03-12 Fidia Farmaceutici Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
CZ302856B6 (cs) 2006-09-27 2011-12-14 Cpn Spol. S R. O. Zpusob prípravy derivátu polysacharidu
AU2007336692B2 (en) 2006-12-22 2013-12-12 Croma-Pharma Gesellschaft M.B.H. Use of polymers
KR20080062092A (ko) 2006-12-29 2008-07-03 주식회사 핸슨바이오텍 세포전달체로서의 히알루론산 유도체 및 이의 제조 방법
JP5329767B2 (ja) 2007-02-26 2013-10-30 帝人株式会社 芳香族コポリアミド繊維の製造装置
RU2350625C2 (ru) * 2007-04-04 2009-03-27 Институт нефтехимии и катализа РАН Производные гиалуроновой кислоты с пониженной биодеградируемостью
CZ2007299A3 (cs) 2007-04-24 2009-02-04 Cpn Spol. S R. O. Príprava nanovláken z polysacharidu a jejich smesí s polyvinylalkoholem
JP5165281B2 (ja) * 2007-06-01 2013-03-21 株式会社バイオベルデ ２反応剤型の医療用含水ゲル形成剤、及び、これより得られるヒアルロン酸ゲル
RU2471867C2 (ru) 2007-06-19 2013-01-10 Тамара П. Уваркина Гиалуронидаза и способ ее применения
FR2921675B1 (fr) 2007-09-28 2010-03-19 Univ Claude Bernard Lyon Filament a base d'acide hyaluronique et son procede d'obtention.
BRPI0908352A2 (pt) 2008-02-11 2015-07-28 Basf Se Processo para produzir estruturas porosas, estrutura porosa, e, uso da mesma
WO2009108100A1 (fr) 2008-02-29 2009-09-03 Ipr-Systems Sweden Ab Composition pour la formation de gels
JP5544107B2 (ja) * 2008-03-31 2014-07-09 花王株式会社 高分子ビルダー
WO2009148405A1 (fr) 2008-06-05 2009-12-10 Agency For Science, Technology And Research Formation d'hydrogel en présence de peroxydase et d'une faible concentration de peroxyde d'hydrogène
FR2934999B1 (fr) 2008-08-13 2011-07-29 Adocia Polysaccharides fonctionnalises par des derives du tryptophane
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
CZ2008705A3 (cs) 2008-11-06 2010-04-14 Cpn S. R. O. Zpusob prípravy DTPA sítovaných derivátu kyseliny hyaluronové a jejich modifikace
ITRM20080636A1 (it) 2008-11-28 2010-05-29 Univ Palermo Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli.
JP2010138276A (ja) 2008-12-11 2010-06-24 Nipro Corp ヒアルロン酸単糸の製造方法
WO2010095052A2 (fr) 2009-02-21 2010-08-26 Sofradim Production Composés et dispositifs médicaux activés par des lieurs solvophobes
WO2010095049A1 (fr) 2009-02-21 2010-08-26 Sofradim Production Fibres réticulées et leur procédé de production par extrusion
WO2010095056A2 (fr) 2009-02-21 2010-08-26 Sofradim Production Dispositifs médicaux à revêtement activé
CZ2009168A3 (cs) 2009-03-17 2010-07-21 Contipro C, A.S. Zpusob prípravy derivátu kyseliny hyaluronové pomocí O-acyl-O´-alkylkarbonátu v prítomnosti substituovaného pyridinu
US8551378B2 (en) 2009-03-24 2013-10-08 North Carolina State University Nanospinning of polymer fibers from sheared solutions
US20120219554A2 (en) 2009-05-14 2012-08-30 Fidia Farmaceutici S.P.A. Extracellular yaluronidase from streptomyces koganeiensis
WO2010138074A1 (fr) 2009-05-29 2010-12-02 Hilborn Joens Systèmes d'administration à base d'acide hyaluronique
WO2011014432A1 (fr) 2009-07-30 2011-02-03 Carbylan Biosurgery, Inc. Compositions de polymère d'acide hyaluronique et procédés associés
KR101103423B1 (ko) 2009-09-04 2012-01-06 아주대학교산학협력단 생체 주입형 조직 접착성 하이드로젤 및 이의 생의학적 용도
WO2011059325A2 (fr) 2009-11-11 2011-05-19 University Of Twente, Institute For Biomedical Technology And Technical Medicine (Mira) Hydrogels à base de dextrane et d'acide hyaluronique
EP2498824B1 (fr) 2009-11-11 2016-04-20 University of Twente, Institute for Biomedical Technology and Technical Medicine (MIRA) Hydrogels à base de polymères de tyramine dextrane et conjugués de tyramine et de polymères naturels
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
CZ302504B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
US8197849B2 (en) 2010-02-12 2012-06-12 National Health Research Institutes Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
CN101897976A (zh) 2010-07-16 2010-12-01 沈阳药科大学 一种药物增溶载体及其制备方法和应用
CZ302994B6 (cs) 2010-12-31 2012-02-08 Cpn S.R.O. Hyaluronová vlákna, zpusob jejich prípravy a použití
CZ304072B6 (cs) 2011-04-26 2013-09-25 Contipro Biotech S.R.O. Amfoterní materiál na bázi sítované kyseliny hyaluronové, zpusob jeho prípravy, materiály obsahující aktivní cinidla uzavrené v síti hyaluronanu, zpusob jejich prípravy a jejich pouzití
CN102154738B (zh) 2011-05-10 2012-08-01 青岛大学 一种红藻琼胶纤维的制备方法
ES2657756T3 (es) 2011-10-18 2018-03-06 Heiq Pty Ltd Proceso de formación de fibra y fibras producidas por medio del proceso
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683064B2 (en) 1997-07-03 2004-01-27 Depuy Acromed, Inc. Cross-linked polysaccharide drug carrier
US6953784B2 (en) 1997-07-03 2005-10-11 Depuy Spine, Inc. Cross-linked polysaccharide drug carrier
WO2002018448A2 (fr) 2000-08-31 2002-03-07 Fidia Farmaceutici S.P.A. Polysaccharides percaboxyles, et procede d'elaboration

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ANGELINO, EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, vol. 19, 2006, pages 4323 - 4326
CARBOHYDR RES, vol. 321, no. 3-4, 1999, pages 228 - 34
CARBOHYDR RES, vol. 327, no. 4, 2000, pages 455 - 61
CORNWELL, TETRAHEDRON LETTERS, vol. 36, no. 46, 1995, pages 8371 - 8374
SAHINER ET AL., J. BIOMATER. SCI. POLYM. ED, vol. 19, no. 2, 2008, pages 223 - 43
SCOTT ET AL., HISTOCHEMIE, vol. 19, no. 2, 1969, pages 155 - 61
WENG ET AL., BIOMATERIALS, vol. 29, no. 31, 2008, pages 4149 - 56
WENG ET AL., J BIOMED MATER RES A, vol. 85, no. 2, 2008, pages 352 - 65

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9403918B2 (en) 2009-12-11 2016-08-02 Contipro Pharma A.S. Oxidized derivative of hyaluronic acid, a method of preparation thereof and a method of modification thereof
US9434791B2 (en) 2009-12-11 2016-09-06 Contipro Pharma A.S. Method of preparation of an oxidized derivative of hyaluronic acid and a method of modification thereof
US10092658B2 (en) 2012-02-07 2018-10-09 Phi Biomed Co., Ltd. Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same
KR101658627B1 (ko) 2012-02-07 2016-09-22 (주)화이바이오메드 경피 전달용 히알루론산-단백질 컨쥬게이트의 제조 방법 및 이에 따라 제조된 경피 전달용 히알루론산-단백질 컨쥬게이트
KR20140136922A (ko) * 2012-02-07 2014-12-01 (주)화이바이오메드 경피 전달용 히알루론산-단백질 컨쥬게이트의 제조 방법 및 이에 따라 제조된 경피 전달용 히알루론산-단백질 컨쥬게이트
US9492586B2 (en) 2012-02-28 2016-11-15 Contipro Biotech S.R.O. Derivatives of hyaluronic acid capable of forming hydrogels
WO2013159757A1 (fr) * 2012-04-25 2013-10-31 Contipro Biotech S.R.O. Dérivé d'hyaluronane réticulé, son procédé de préparation, hydrogel et microfibres à base du dérivé
RU2647859C2 (ru) * 2012-08-08 2018-03-21 Контипро А.С. Производное гиалуроновой кислоты, способ его получения, способ его модификации и его применение
KR20150040966A (ko) * 2012-08-08 2015-04-15 콘티프로 바이오테크 에스.알.오. 히알루론산 유도체, 이의 제조 방법, 이의 변형 방법, 및 이의 용도
KR102060026B1 (ko) 2012-08-08 2019-12-27 콘티프로 에이.에스. 히알루론산 유도체, 이의 제조 방법, 이의 변형 방법, 및 이의 용도
WO2014023272A1 (fr) 2012-08-08 2014-02-13 Contipro Biotech S.R.O. Dérivé d'acide hyaluronique, procédé de préparation de celui-ci, procédé de modification de celui-ci et d'utilisation de celui-ci
US9522966B2 (en) 2012-08-08 2016-12-20 Contipro Biotech S.R.O. Hyaluronic acid derivative, method of preparation thereof, method of modification thereof and use thereof
US9999678B2 (en) 2012-11-27 2018-06-19 Contipro A.S. C6-C18-acylated derivative of hyaluronic acid and method of preparation thereof
WO2014082610A1 (fr) 2012-11-27 2014-06-05 Contipro Biotech S.R.O. Fibres sans fin à base d'hyaluronane sélectivement oxydé en position 6 du groupe n-acétyl-d-glucosamine, leur préparation et utilisation, filés, fibres courtes, fils et tissus constitués de celles-ci et procédé pour la modification de celles-ci
US10023658B2 (en) 2014-03-11 2018-07-17 Contipro A.S. Conjugates of oligomer of hyaluronic acid or of a salt thereof, method of preparation thereof and use thereof
US10617711B2 (en) 2014-06-30 2020-04-14 Contipro A.S. Antitumor composition based on hyaluronic acid and inorganic nanoparticles, method of preparation thereof and use thereof
US10689464B2 (en) 2015-03-09 2020-06-23 Contipro A.S. Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of preparation and use thereof
WO2016202314A1 (fr) 2015-06-15 2016-12-22 Contipro A.S. Procédé de réticulation de polysaccharides à l'aide de groupes protecteurs photoamovibles
US10759878B2 (en) 2015-06-15 2020-09-01 Contipro A.S. Method of crosslinking of polysaccharides using photoremovable protecting groups
WO2016206661A1 (fr) 2015-06-26 2016-12-29 Contipro A.S. Dérivés de polysaccharides sulfatés, procédé de préparation, modification et utilisation correspondants
US10414832B2 (en) 2015-06-26 2019-09-17 Contipro A.S Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof
CZ308106B6 (cs) * 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
US10618984B2 (en) 2016-06-27 2020-04-14 Contipro A.S. Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof

Also Published As

Publication number Publication date
EP2510017A2 (fr) 2012-10-17
CZ2009836A3 (cs) 2011-06-22
CZ302504B6 (cs) 2011-06-22
BR112012013954A2 (pt) 2016-06-07
WO2011069474A3 (fr) 2013-03-14
US20120245323A1 (en) 2012-09-27
KR101710432B1 (ko) 2017-02-27
JP2013513671A (ja) 2013-04-22
US9403918B2 (en) 2016-08-02
RU2012122313A (ru) 2014-01-20
BR112012013954B8 (pt) 2021-05-25
DK2510017T3 (en) 2015-03-23
PL2510017T3 (pl) 2015-06-30
EP2510017B1 (fr) 2015-01-21
JP5945504B2 (ja) 2016-07-05
KR20120091449A (ko) 2012-08-17
RU2550602C2 (ru) 2015-05-10
ES2531292T3 (es) 2015-03-12
BR112012013954B1 (pt) 2020-12-22

Similar Documents

Publication Publication Date Title
EP2510017B1 (fr) Dérivé oxydé d'acide hyaluronique, procédé d'élaboration et procédé de modification
EP2510016B1 (fr) Procédé d'élaboration de dérivé oxydé d'acide hyaluronique et procédé de modification
US10716959B2 (en) Polymer-flavonoid conjugates and hydrogels for biomedical applications
US7683038B2 (en) Percarboxylated polysaccharides, and a process for their preparation
RU2647859C2 (ru) Производное гиалуроновой кислоты, способ его получения, способ его модификации и его применение
JP6649892B2 (ja) ヒアルロン酸オリゴマーの複合体又はその塩，その調製法及びその使用
US20160159937A1 (en) Polysaccharide derivatives including an alkene unit and thiol-click chemical coupling reaction
JP2018519391A (ja) 硫酸化多糖類の誘導体，ならびにその調製，修飾及び使用方法
CZ2004579A3 (cs) Způsob přípravy derivátů hyaluronanu vázaných karbamátovou vazbou

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10812976

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010812976

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012542355

Country of ref document: JP

Ref document number: 13514759

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20127017920

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2012122313

Country of ref document: RU

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012013954

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012013954

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120611